Strategic partnerships Levitabio has recently collaborated with Cytiva to deliver a single-cell workflow for genomics researchers, indicating strong momentum in partnering with established players to expand reach. Target potential with collaboration-focused campaigns and co-marketing opportunities to access broad academic and industry networks.

Product expansion The LeviCell EOS system launch for higher throughput cell isolation signals capacity for scaled research workflows. Develop sales plays around throughput, automation-friendly features, and integration with existing lab pipelines to attract large labs and CROs seeking faster sample processing.

Immunology focus Introduced LeviSelect depletion and enrichment kits for immunology research, presenting entry points for labs focused on immune profiling and cell purification. Consider targeted outreach to immunology departments and contract research organizations needing precise cell subset enrichment.

End-to-end value Position LevitasBio as an end-to-end solution provider for sample processing and cellular analysis, offering both hardware (LeviCell systems) and consumables (LeviSelect kits). Cross-sell opportunities exist with labs seeking turnkey workflows from sample prep to data insight.

Growth readiness Funding history and revenue scale indicate a growing company with room for expansion into larger enterprise accounts. Prioritize enterprise sales motions, global commercial operations, and partner-led deployments to accelerate adoption across larger life sciences organizations.